Search

Author/Creator Massare, Michael J

1. Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial. Issue 1 (January 2022)

Authors:
Shinde, Vivek; Cho, Iksung; Plested, Joyce S; Agrawal, Sapeckshita; Fiske, Jamie; Cai, Rongman; Zhou, Haixia; Pham, Xuan; Zhu, Mingzhu; Cloney-Clark, Shane; Wang, Nan; Zhou, Bin; Lewis, Maggie; Price-Abbott, Patty; Patel, Nita; Massare, Michael J; Smith, Gale; Keech, Cheryl; Fries, Louis; Glenn, ...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 1(2022)
Page Start:
73
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine. (4th November 2020)

Authors:
Shinde, Vivek; Cai, Rongman; Plested, Joyce; Cho, Iksung; Fiske, Jamie; Pham, Xuan; Zhu, Mingzhu; Cloney-Clark, Shane; Wang, Nan; Zhou, Haixia; Zhou, Bin; Patel, Nita; Massare, Michael J; Fix, Amy; Spindler, Michelle; Thomas, David Nigel; Smith, Gale; Fries, Louis; Glenn, Gregory M
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 11(2021)
Page Start:
e4278
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search